We presented outcomes of SCT for T315I+ CML patients, with the majority of HID-SCT.
Survival outcomes were promising for patients transplanted in the CP and AP/AP-CPn.
We demonstrated detailed intervention based on BCR-ABL after SCT for T315I+ patients.